(Q47832799)

English

Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

coronary artery bypass surgery

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Richter WO

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

Donner MG

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

Höfling B

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

Schwandt P

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

47

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

863-868

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Cadiovascular complications of homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HEL

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concen

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990127-5

7 January 2021

Identifiers

10.1016/S0026-0495(98)90127-5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9667236

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47832799&oldid=2172267204"